Fasting’s potential in fighting cognitive decline needs more human trials

FHS
April 2, 2024
4:14 am

Despite promising animal studies on fasting and caloric restrictions for neurodegenerative diseases, human clinical trials are scarce, underscoring the need for more research to validate these interventions for cognitive decline.

Holistic lifestyle interventions outshine drugs in preventing cardiometabolic diseases

Comprehensive lifestyle interventions prevent cardiometabolic diseases effectively but face challenges in routine care and require supportive policies for lasting impact.

December 4, 2024

TORL scores $158m in Series B2 to advance ADC cancer therapies

Share this article TORL plans to use the funds to finance multiple ongoing Phase I trials. Image Credit: Olivier Le Moal / Shutterstock. TORL BioTherapeutics

April 10, 2024

Affordable air quality monitoring reveals rural children’s exposure to harmful particulate matter

Researchers discuss the development of a low-cost air pollution measurement system.

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.